CG Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

CG Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.22M	Sell	20,850 -2,910	-12%	-$159K	0.45%	65
2016 Q3	$1.28M	Sell	23,760 -4,200	-15%	-$270K	0.48%	61
2016 Q2	$2.06M	Sell	27,960 -3,479	-11%	-$246K	0.82%	47
2016 Q1	$2.01M	Sell	31,439 -15,575	-33%	-$982K	0.8%	46
2015 Q4	$3.23M	Buy	47,014 +385	+0.8%	+$25.4K	1.28%	27
2015 Q3	$2.76M	Buy	46,629 +20,729	+80%	+$1.32M	1.17%	29
2015 Q2	$1.72M	Buy	25,900 +1,900	+8%	+$125K	0.66%	50
2015 Q1	$1.55M	Hold	24,000	–	–	0.6%	57
2014 Q4	$1.42M	Buy	24,000 +650	+3%	+$36.7K	0.56%	56
2014 Q3	$1.2M	Buy	23,350 +5,275	+29%	+$263K	0.49%	64
2014 Q2	$877K	Sell	18,075 -12,770	-41%	-$629K	0.37%	72
2014 Q1	$1.6M	Buy	30,845 +1,025	+3%	+$54.5K	0.72%	56
2013 Q4	$1.58M	Buy	+29,820	New	+$1.52M	0.73%	51

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

CG Asset Management's BMY Position: Q4 2016 in Review

CG Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 12% in Q4 2016, selling an estimated $159K and leaving 20,850 shares worth $1.22M. The position accounts for 0.45% of the portfolio, ranked #65.

CG Asset Management first reported a position in BMY in Q4 2013 and has held it in 13 quarters since. The position peaked at $3.23M in Q4 2015. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

CG Asset Management held 20,850 shares of Bristol-Myers Squibb worth $1.22M as of Q4 2016.
CG Asset Management sold 2,910 Bristol-Myers Squibb shares in Q4 2016, an estimated $159K.
Bristol-Myers Squibb made up 0.45% of CG Asset Management's portfolio in Q4 2016, its #65 holding.
CG Asset Management first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 13 quarters since.
CG Asset Management's Bristol-Myers Squibb position peaked at $3.23M in Q4 2015.
1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on CG Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.